Related Articles
Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer
Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway
Thyroid hormones suppress FOXM1 expression to reduce liver cancer progression
FOXM1 is overexpressed in B-acute lymphoblastic leukemia (B-ALL) and its inhibition sensitizes B-ALL cells to chemotherapeutic drugs
miR‑34a inhibits esophageal squamous cell carcinoma progression via regulation of FOXM1